France
University of Strasbourg - Centre d'Investigation Clinique (CIC) INSERM 1434
SARS-CoV-2, COVID-19 vaccine, Immunological efficacy, Randomized trial, Heterologous vaccination, mRNA vaccine, BNT162b2 vaccine, mRNA-1273 vaccine.